AUG 26, 2026 · JOURNAL ARTICLE
Respiratory Syncytial Virus Vaccination as Cardiopulmonary and Cardiovascular Risk Mitigation in Adults with Heart Disease
Journal of Clinical Medicine
A narratively synthesized review proposing a clinical implementation framework for RSV vaccination in cardiovascular disease, grounded in trial evidence for respiratory but not cardiovascular endpoints.
Reported
Primary age target≥75 years and those aged 50–74 years with h…